Published in Radiother Oncol on June 01, 2005
Class solution in inverse planned HDR prostate brachytherapy for dose escalation of DIL defined by combined MRI/MRSI. Radiother Oncol (2008) 0.87
Canadian prostate brachytherapy in 2012. Can Urol Assoc J (2013) 0.82
After low and high dose-rate interstitial brachytherapy followed by IMRT radiotherapy for intermediate and high risk prostate cancer. BMC Cancer (2016) 0.80
Image-Guided High-Dose-Rate (HDR) Boost Localization Using MRI/MR Spectroscopy: A Correlation Study with Biopsy. Cureus (2016) 0.75
Dosimetric evaluation of high-dose-rate interstitial brachytherapy boost treatments for localized prostate cancer. Strahlenther Onkol (2010) 0.75
The impact of a single-layer or double-layer closure on uterine rupture. Am J Obstet Gynecol (2002) 3.84
Cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) trial. Circulation (2013) 2.90
Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients. J Clin Oncol (2005) 2.79
Left ventricular versus simultaneous biventricular pacing in patients with heart failure and a QRS complex ≥120 milliseconds. Circulation (2011) 2.36
Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer. Int J Radiat Oncol Biol Phys (2006) 2.33
A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients. J Natl Cancer Inst (2005) 2.04
Measurement accuracy and cerenkov removal for high performance, high spatial resolution scintillation dosimetry. Med Phys (2006) 1.82
Megavoltage cone-beam CT: system description and clinical applications. Med Dosim (2006) 1.74
Antihypertensive drug use and the risk of prostate cancer (Canada). Cancer Causes Control (2004) 1.63
Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guérin immunotherapy. Eur Urol (2009) 1.59
Water-equivalent dosimeter array for small-field external beam radiotherapy. Med Phys (2007) 1.58
Polymorphisms of the human NRAMP1 gene are associated with response to bacillus Calmette-Guerin immunotherapy for superficial bladder cancer. J Urol (2006) 1.56
Quantitative hyperemic reactivity in opposed limbs during myocardial perfusion imaging: a new marker of coronary artery disease. J Am Coll Cardiol (2004) 1.53
The evolution of brachytherapy treatment planning. Med Phys (2009) 1.50
Maintenance bacillus Calmette-Guérin in high-risk nonmuscle-invasive bladder cancer: how much is enough? Cancer (2008) 1.48
Fast, systematic, and continuous delirium assessment in hospitalized patients: the nursing delirium screening scale. J Pain Symptom Manage (2005) 1.47
Inverse planning simulated annealing for magnetic resonance imaging-based intracavitary high-dose-rate brachytherapy for cervical cancer. Brachytherapy (2008) 1.46
American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy. Brachytherapy (2012) 1.45
Toward a real-time in vivo dosimetry system using plastic scintillation detectors. Int J Radiat Oncol Biol Phys (2010) 1.45
MRI-guided HDR prostate brachytherapy in standard 1.5T scanner. Int J Radiat Oncol Biol Phys (2004) 1.44
Assessment of cytotoxicity of quantum dots and gold nanoparticles using cell-based impedance spectroscopy. Anal Chem (2008) 1.43
Physics strategies for sparing neural stem cells during whole-brain radiation treatments. Med Phys (2011) 1.43
Prostate movement during simulation resulting from retrograde urethrogram compared with "natural" prostate movement. Int J Radiat Oncol Biol Phys (2004) 1.39
Clinical prototype of a plastic water-equivalent scintillating fiber dosimeter array for QA applications. Med Phys (2008) 1.38
Costs associated with resource utilization during the palliative phase of care: a Canadian perspective. Palliat Med (2009) 1.38
Sensorless motion planning for medical needle insertion in deformable tissues. IEEE Trans Inf Technol Biomed (2008) 1.38
Registration of MR prostate images with biomechanical modeling and nonlinear parameter estimation. Med Phys (2006) 1.30
An adaptive approach to metal artifact reduction in helical computed tomography for radiation therapy treatment planning: experimental and clinical studies. Int J Radiat Oncol Biol Phys (2005) 1.29
Measurements of intrafraction motion and interfraction and intrafraction rotation of prostate by three-dimensional analysis of daily portal imaging with radiopaque markers. Int J Radiat Oncol Biol Phys (2004) 1.28
Plastic scintillation dosimetry: optimal selection of scintillating fibers and scintillators. Med Phys (2005) 1.27
Daily electronic portal imaging of implanted gold seed fiducials in patients undergoing radiotherapy after radical prostatectomy. Int J Radiat Oncol Biol Phys (2007) 1.27
Correction of CT artifacts and its influence on Monte Carlo dose calculations. Med Phys (2007) 1.27
The need for application-based adaptation of deformable image registration. Med Phys (2013) 1.23
A pilot study: the Noninvasive Surface Cooling Thermoregulatory System for Mild Hypothermia Induction in Acute Myocardial Infarction (the NICAMI Study). Am Heart J (2005) 1.20
Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging. Int J Radiat Oncol Biol Phys (2004) 1.19
An in-depth analysis of electric cell-substrate impedance sensing to study the attachment and spreading of mammalian cells. Anal Chem (2002) 1.18
Psychoactive medications and risk of delirium in hospitalized cancer patients. J Clin Oncol (2005) 1.17
Significance of MMP-2 expression in prostate cancer: an immunohistochemical study. Cancer Res (2003) 1.16
Simulating needle insertion and radioactive seed implantation for prostate brachytherapy. Stud Health Technol Inform (2003) 1.16
Daily electronic portal imaging for morbidly obese men undergoing radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys (2004) 1.15
Characterizing the response of miniature scintillation detectors when irradiated with proton beams. Phys Med Biol (2008) 1.14
Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach. Anal Chem (2002) 1.12
Dual-energy CT-based material extraction for tissue segmentation in Monte Carlo dose calculations. Phys Med Biol (2008) 1.10
Improved function and myocardial repair of infarcted heart by intracoronary injection of mesenchymal stem cell-derived growth factors. J Cardiovasc Transl Res (2010) 1.09
Phase II trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: preliminary results of RTOG 0321. Int J Radiat Oncol Biol Phys (2010) 1.09
Quality assurance for image-guided radiation therapy utilizing CT-based technologies: a report of the AAPM TG-179. Med Phys (2012) 1.09
Site-specific deformable imaging registration algorithm selection using patient-based simulated deformations. Med Phys (2013) 1.09
Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys (2006) 1.08
Low dose megavoltage cone beam computed tomography with an unflattened 4 MV beam from a carbon target. Med Phys (2008) 1.06
Laparoscopic sentinel node mapping in early-stage cervical cancer. Gynecol Oncol (2003) 1.05
Early clinical experience with anatomy-based inverse planning dose optimization for high-dose-rate boost of the prostate. Int J Radiat Oncol Biol Phys (2002) 1.04
Opioid medications and longitudinal risk of delirium in hospitalized cancer patients. Cancer (2007) 1.04
Insulin-like growth factor binding protein 2: an androgen-dependent predictor of prostate cancer survival. Eur Urol (2005) 1.03
Surface preparation and coupling in plastic scintillator dosimetry. Med Phys (2006) 1.03
Technical note: removing the stem effect when performing Ir-192 HDR brachytherapy in vivo dosimetry using plastic scintillation detectors: a relevant and necessary step. Med Phys (2011) 1.02
Imaging biomarkers in atherosclerosis trials. Circ Cardiovasc Imaging (2011) 1.02
The prostate cancer risk stratification (ProCaRS) project: recursive partitioning risk stratification analysis. Radiother Oncol (2013) 1.01
The hemodynamically unstable patient in the intensive care unit: hemodynamic vs. transesophageal echocardiographic monitoring. Crit Care Med (2002) 1.01
Sensitivity and specificity of the critical-care pain observation tool for the detection of pain in intubated adults after cardiac surgery. J Pain Symptom Manage (2008) 1.01
Role of immunohistochemical overexpression of matrix metalloproteinases MMP-2 and MMP-11 in the prognosis of death by ovarian cancer. Am J Clin Pathol (2008) 1.00
Effects of the tumor necrosis factor-α antagonist adalimumab on arterial inflammation assessed by positron emission tomography in patients with psoriasis: results of a randomized controlled trial. Circ Cardiovasc Imaging (2012) 1.00
Enhancements to commissioning techniques and quality assurance of brachytherapy treatment planning systems that use model-based dose calculation algorithms. Med Phys (2010) 0.99
A phantom study of an in vivo dosimetry system using plastic scintillation detectors for real-time verification of 192Ir HDR brachytherapy. Med Phys (2011) 0.99
A new water-equivalent 2D plastic scintillation detectors array for the dosimetry of megavoltage energy photon beams in radiation therapy. Med Phys (2011) 0.99
Measurement of craniocaudal catheter displacement between fractions in computed tomography-based high dose rate brachytherapy of prostate cancer. J Appl Clin Med Phys (2007) 0.99
Patient dose considerations for routine megavoltage cone-beam CT imaging. Med Phys (2007) 0.98
Influence of smoking and alcohol drinking behaviors on treatment outcomes of patients with squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys (2008) 0.98
Membrane-type-1 matrix metalloproteinase, matrix metalloproteinase 2, and tissue inhibitor of matrix proteinase 2 in prostate cancer: identification of patients with poor prognosis by immunohistochemistry. Hum Pathol (2008) 0.98
Comparison of inverse planning simulated annealing and geometrical optimization for prostate high-dose-rate brachytherapy. Brachytherapy (2004) 0.98
American Society for Therapeutic Radiology and Oncology (ASTRO) Emerging Technology Committee report on electronic brachytherapy. Int J Radiat Oncol Biol Phys (2010) 0.97
Prognostic significance of lymphovascular invasion in surgically cured rectal carcinoma. Am J Surg (2005) 0.95
In-phantom dose verification of prostate IMRT and VMAT deliveries using plastic scintillation detectors. Radiat Meas (2012) 0.95
Extracting atomic numbers and electron densities from a dual source dual energy CT scanner: experiments and a simulation model. Radiother Oncol (2011) 0.95
Positional stability of electromagnetic transponders used for prostate localization and continuous, real-time tracking. Int J Radiat Oncol Biol Phys (2007) 0.94
Energy and integrated dose dependence of MOSFET dosimeter sensitivity for irradiation energies between 30 kV and 60Co. Med Phys (2006) 0.94
Expandable and rigid endorectal coils for prostate MRI: impact on prostate distortion and rigid image registration. Med Phys (2005) 0.94
A mathematical formalism for hyperspectral, multipoint plastic scintillation detectors. Phys Med Biol (2012) 0.93
Dose calculation using megavoltage cone-beam CT. Int J Radiat Oncol Biol Phys (2007) 0.93
Validating plastic scintillation detectors for photon dosimetry in the radiologic energy range. Med Phys (2012) 0.93
ImmunoCyt/uCyt+ improves the sensitivity of urine cytology in patients followed for urothelial carcinoma. Mod Pathol (2005) 0.93
Optimization of HDR brachytherapy dose distributions using linear programming with penalty costs. Med Phys (2006) 0.92
Inverse planning for interstitial gynecologic template brachytherapy: truly anatomy-based planning. Int J Radiat Oncol Biol Phys (2002) 0.92
Development of a novel multi-point plastic scintillation detector with a single optical transmission line for radiation dose measurement. Phys Med Biol (2012) 0.92
Impact of interseed attenuation and tissue composition for permanent prostate implants. Med Phys (2006) 0.92
Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition. Med Phys (2010) 0.92
Exploring (57)Co as a new isotope for brachytherapy applications. Med Phys (2012) 0.91
3D inverse treatment planning for the tandem and ovoid applicator in cervical cancer. Int J Radiat Oncol Biol Phys (2005) 0.90